Christopher B Granger

11 papers · 488 indexed citations

Immediate Impact

10 from Science/Nature 90 hit

Sub-graph 1 of 21

Citing Papers

Reteplase versus Alteplase for Acute Ischemic Stroke

2024 Hit

Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke

2015 Hit

1 intermediate paper

Works of Christopher B Granger being referenced

Diabetic Retinopathy Should Not Be a Contraindication to Thrombolytic Therapy for Acute Myocardial Infarction: Review of Ocular Hemorrhage Incidence and Location in the GUSTO-I Trial fn1fn1This study was supported by Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genentech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.

1997

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Christopher B Granger	390	163	126	110	29	11	488
Yuri A. Deychak	349 0.9×	157 1.0×	162 1.3×	75 0.7×	14 0.5×	8	431
Scott L. Woodfield	320 0.8×	102 0.6×	177 1.4×	75 0.7×	14 0.5×	8	423
Bradley Collins	371 1.0×	98 0.6×	186 1.5×	64 0.6×	39 1.3×	16	540
Naoki Nozawa	335 0.9×	156 1.0×	119 0.9×	25 0.2×	34 1.2×	15	419
Kyle A. Arsenault	247 0.6×	49 0.3×	152 1.2×	67 0.6×	18 0.6×	9	407
S Moulopoulos	339 0.9×	117 0.7×	108 0.9×	19 0.2×	36 1.2×	8	406
Mary Jane Hess	253 0.6×	345 2.1×	222 1.8×	27 0.2×	39 1.3×	7	527
Frants Pedersen	331 0.8×	78 0.5×	94 0.7×	37 0.3×	46 1.6×	17	438
William R. Maddox	359 0.9×	33 0.2×	89 0.7×	102 0.9×	21 0.7×	19	526
Eiji Hishida	326 0.8×	82 0.5×	123 1.0×	16 0.1×	55 1.9×	15	464

All Works

Loading papers...